Although innovations in cancer care are rapidly emerging, systemic and social barriers continue to challenge the delivery of optimal care. The intersection of cutting-edge oncology treatment with ...

A growing body of evidence shows that pediatric cardiology remains stuck in the first 2 generations of health equity research ...

Pretreatment eosinophilia in NSCLC patients is associated with increased immune-related adverse events and reduced progression-free survival when treated with ICIs. The review included 11 ...

Value-based care and early palliative care are strategies to mitigate rising cancer treatment costs due to longer patient ...

Prioritizing education and shared decision-making can help patients with newly diagnosed heart failure feel less overwhelmed, ...

Sotatercept (Winrevair; Merck) is enhancing treatment for patients with pulmonary arterial hypertension (PAH), explained ...

Navar presented the results of the phase 3 CORALreef Lipids trial, evaluating the oral PCSK9 inhibitor enlicitide in adult ...

Navar A. Efficacy and safety of enlicitide, an oral PCSK9 inhibitor, for lowering LDL cholesterol in adults with or at-risk for ASCVD: the phase 3 CORALreef lipids trial. Presented at: AHA 2025 ...

Older adults face unique barriers in hypertension management, including comorbidities, mobility limitations, and medication adherence challenges, impacting digital health tool effectiveness. Trials ...

Efficacy and safety of subcutaneous self-administered gefurulimab in generalized myasthenia gravis: topline results from a ...

The introduction of more stringent work requirements for those enrolling or renewing their Medicaid coverage can affect both children and adults. The One Big Beautiful Bill Act (OBBBA) introduced a ...

Based on findings from her study, "Pricing and Insurance Networks in Outpatient Surgery Markets," lead investigator Xiaoxi Zhao, PhD, recommends aligning patient and insurer incentives to encourage ...